Indefinite Delivery Contract N6264515D6000

The Defense Health Agency awarded a blanket purchase agreement to The Compounding Center Inc. to provide various pharmaceutical supplies and compounded medications. Under four firm fixed price call contracts valued between $25,000 to $150,000 placed against the agreement, the contractor will deliver shortage pharmaceuticals, compounded drugs, and chemical compounds to Walter Reed National Military Medical Center in Bethesda, Maryland. Performance is scheduled to take place through various...

This is a single award Indefinite Delivery Contract issued by the Department of the Army Medical Command to Complete Pharmacy And Medical Solutions, LLC, a for-profit limited liability company. The contract is for the supply of compounded pharmaceutical products, with a period of performance ending on September 30, 2022 and a potential total value of $1,342,433.30. The specific task order provided is for the supply of ROPIVACAINE PF 0.2% 100 ML CADD, with a period of performance ending on...

Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated, was awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network 17 (VISN 17) on November 1, 2025, to provide pharmacy compounding services for oncology drugs at the Dallas Veterans Affairs Healthcare System. The contract has a ceiling value of $6,000,000 and extends through October 31, 2030. The prime contractor will deliver chemotherapy preparation services to the North Texas VA...

Jubilant Draximage Radiopharmacies, Inc., operating as Jubilant Radiopharma, was awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs, effective February 1, 2025, through January 31, 2028. The contract has a ceiling value of $740,177.94 and carries no set-aside designation, making it available through open competition. The contractor will supply radiopharmaceuticals and nuclear medicine products to support...

The Department of the Army Medical Command awarded a single-award blanket purchase agreement to Complete Pharmacy And Medical Solutions, LLC on October 1, 2018 to procure specialized compounded intravenous solutions. The potential value of the agreement is $2,500,000 with a period of performance through September 30, 2023 or until the maximum value is reached. The originating pre-solicitation notice sought information to establish blanket purchase agreements for various pharmaceutical supplies...

Genzyme Corporation, operating as Sanofi Genzyme, holds a multiple-award Federal Supply Schedule contract (FSS-61-IB) valued at $659.7 million for Pharmaceuticals and Drugs, awarded by the Department of Veterans Affairs Veterans Health Administration on May 15, 2019, with a completion date of April 30, 2026. This indefinite delivery vehicle establishes a master contract framework enabling the VA to issue delivery orders for a broad range of pharmaceutical products across its healthcare system....

Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer specializing in vaccine production, was awarded a multiple-award Federal Supply Schedule contract under General Services Administration schedule 61-IB (Pharmaceuticals and Drugs) with a ceiling value of $634 million and an ultimate completion date of April 14, 2027. The contract was awarded on April 15, 2022, to Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs, without set-aside...

Golden State Medical Supply, Inc. has been awarded a multiple-award Federal Supply Schedule contract (GSS-61-IB, Pharmaceuticals and Drugs) by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs, with an award date of June 15, 2023, and an ultimate completion date of June 14, 2028. The contract carries a ceiling value of $5.91 billion and operates under no set-aside restrictions, indicating competitive procurement. As a prime contractor, Golden...

Insmed Inc., a biopharmaceutical company headquartered in Bridgewater, New Jersey, was awarded a Multiple Award Federal Supply Schedule contract by the Veterans Integrated Service Network 12 (a civilian component of the Department of Veterans Affairs) on June 1, 2024, for the supply of drugs, pharmaceuticals, and hematology-related products under General Services Administration Schedule 65 IB. The contract carries a ceiling value of $24,153,150 with an ultimate completion date of May 31, 2029,...

Exelan Pharmaceuticals Inc., a foreign-owned pharmaceutical manufacturing and distribution company headquartered in Boca Raton, Florida, holds a multiple award Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs with a ceiling value of $3.08 billion and a performance period extending through September 14, 2026. Awarded by the Veterans Integrated Service Network 12 on September 15, 2020, this GSA Schedule contract was established without set-aside restrictions, allowing...